Deschloroetizolam 2mg Blotters
€ 150,00 – € 1.600,00Price range: € 150,00 through € 1.600,00
Deschloroetizolam Blotters are described as a laboratory research preparation associated with deschloroetizolam, also referred to in the supplied source as Etizolam-2.
The compound belongs to the thienotriazolodiazepine family and is described as a structural analogue of etizolam that lacks the chlorine substituent on the phenyl ring. Deschloroetizolam Blotters
This structural distinction provides a basis for analytical investigations involving heterocyclic chemical identity, molecular characterization, and comparative examination of related thienodiazepine derivatives.
The supplied information describes a specialized paper substrate carrying a stated quantity of the named compound.
However, claims concerning ingredient purity, HPLC verification, mass-spectrometric identification, precision deposition, and finished-unit consistency require supporting batch-specific documentation.
The material is not established as a certified reference standard or validated quantitative calibrator.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Deschloroetizolam Blotters 2mg – Thienotriazolodiazepine Research Material
Product Overview
Deschloroetizolam Blotters are described in the supplied information as a laboratory research preparation associated with deschloroetizolam, a synthetic compound belonging to the thienotriazolodiazepine chemical family.
The source also identifies the compound as Etizolam-2.
Deschloroetizolam is described as a structural analogue of etizolam that lacks the chlorine substituent present on the phenyl ring of the related compound.
This structural distinction provides a basis for scientific comparison of substituted thienotriazolodiazepine derivatives.
The supplied material is described as a blotter preparation using a specialized paper substrate.
Raw Lab Chems presents this material exclusively within a Research Use Only framework.
The stated presentation does not independently establish the actual chemical identity, ingredient purity, finished-unit composition, or content uniformity.
The source also refers to analytical verification, precision deposition, and controlled manufacturing conditions.
These statements remain unverified until supported by documentation associated with the actual product and batch.
No clinical, therapeutic, diagnostic, dietary, or consumer-oriented application is represented by this description.
Chemical Identity & Classification
Deschloroetizolam is described as a synthetic compound belonging to the thienotriazolodiazepine chemical family.
The source identifies it as a deschlorinated structural analogue of etizolam.
Its molecular framework includes a thiophene-containing fused ring system and a triazole-associated diazepine structure.
The supplied source provides the following chemical-reference information:
- Common name: Deschloroetizolam
- Source-provided alternative name: Etizolam-2
- Reported systematic name: 2-Ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
- Chemical classification: Thienotriazolodiazepine derivative
- Reported molecular formula: C17H16N4S
- Structural relationship: Deschlorinated analogue of etizolam
No CAS Registry Number or molecular weight was supplied.
These identifiers are reproduced from the source and do not independently establish the composition of the actual product.
The source does not provide a verified salt-form designation or complete formulation specification.
This distinction matters because the composition of a finished blotter may differ from the molecular formula of the named chemical.
The source describes deschloroetizolam as a compound relevant to the study of halogen substitution in related heterocyclic structures.
That relationship provides chemical context but does not establish the actual product’s purity or structural identity.
Researchers seeking public chemical-reference information may consult PubChem and confirm that any selected database entry corresponds to the intended compound and chemical form.
Chemical & Physical Characteristics
The supplied product is described as a specialized paper blotter containing deschloroetizolam.
No product-specific inspection report, blotter-substrate specification, excipient list, or formulation-characterization record was provided.
The stated physical presentation therefore remains a source-provided description.
The deschloroetizolam molecular framework contains a fused thiophene-associated diazepine system and a triazole ring.
The absence of a chlorine substituent, as described in the source, distinguishes its proposed structure from that of etizolam.
These structural differences provide a basis for analytical comparison.
However, structural similarity does not establish identical physical properties, stability, impurity profiles, or analytical behavior.
The source identifies electronic characteristics, molecular stability, and comparative structural analysis as scientific topics.
No product-specific degradation measurements, stability data, or experimentally verified physicochemical profile accompanied this description.
The source also does not provide a verified melting point, quantitative solubility profile, density, substrate-absorption specification, or hygroscopicity measurement.
The finished blotter preparation may contain substrate materials and additional formulation ingredients.
No verified blotter dimensions, substrate composition, component distribution, or content-uniformity measurements accompanied the supplied information.
The source recommends cool, dry storage protected from moisture and ultraviolet light.
No validated stability study or experimentally established shelf-life specification accompanied this recommendation.
Purity & Analytical Verification
The supplied description claims purity of at least 98%, with HPLC cited as a verification method.
It also refers to mass spectrometry for structural identification and precision deposition for finished-unit consistency.
However, no actual batch-specific Certificate of Analysis, chromatogram, mass spectrum, or independent laboratory report was provided.
Accordingly, the stated purity threshold is not independently confirmed for the material described here.
The source identifies LC-MS and GC-MS as analytical techniques associated with deschloroetizolam investigation.
Such methods may provide information concerning chemical identity, structural characteristics, impurity profiles, and analytical specificity.
However, naming an analytical technique does not establish that it was performed on the actual product.
An important distinction exists between the purity of the chemical ingredient and the composition of the finished blotter.
Even if ingredient purity were independently established, that finding would not by itself verify the labeled component amount, total formulation, or consistency between individual units.
The source also references comparative chemical studies involving deschloroetizolam and etizolam.
These references provide scientific context rather than evidence of the product’s verified performance in a particular laboratory method.
No certified reference-material status, validated finished-unit content, or independently established purity specification is asserted.
Quality Control & Batch Integrity
The supplied source claims that individual batches undergo HPLC testing to confirm purity and labeled component content.
It also describes mass-spectrometric verification, precision deposition, and manufacturing controls intended to support uniformity between individual blotters.
No actual certificate, independent testing record, manufacturing audit, laboratory accreditation document, or batch-specific quality-control report accompanied these statements.
They therefore remain unverified supplier claims. Deschloroetizolam Blotters
For reproducible laboratory investigation, useful records may include supplier identification, batch number, chemical identifier, receipt date, storage history, and available analytical findings.
For blotter preparations, the identity and purity of the named ingredient should be distinguished from the composition and consistency of the finished units.
The supplied information does not establish independently verified content uniformity, substrate composition, or quantitative accuracy of the labeled amount.
Where a material is described as suitable for reference-standard work, researchers should distinguish ordinary catalog material from a certified reference material.
The supplied information does not establish certified reference-material status, metrological traceability, or an assigned measurement uncertainty.
Claims of consistent purity, identity, formulation quality, or manufacturing compliance should be supported by actual analytical records rather than inferred from catalog terminology.
Safety, Handling & Laboratory Precautions
Deschloroetizolam is a benzodiazepine-related compound requiring appropriate institutional risk assessment and controlled laboratory handling.
Its structural relationship to etizolam does not establish a verified product-specific toxicological profile. Deschloroetizolam Blotters
Research personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.
Laboratory precautions should address access restrictions, protective equipment, contamination prevention, accidental exposure, environmental release, and chemical-waste disposal.
The compound’s relationship to other thienotriazolodiazepines does not establish safety for human or veterinary exposure.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.
Because the actual purity and blotter composition have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.
The blotter presentation must not be interpreted as evidence of pharmaceutical suitability or authorization for personal use.
Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.
Packaging, Labeling & Storage
The supplied source describes moisture-resistant, light-shielded packaging intended to protect material integrity during transportation. Deschloroetizolam Blotters
No packaging-validation study, verified container specification, or actual shipment-condition record accompanied this claim.
The source recommends cool, dry storage protected from moisture and ultraviolet light, with a suggested temperature range of 15–25°C.
No validated stability data was provided to establish that this temperature range is necessary or sufficient for a particular shelf life.
The source also claims that shipping arrangements support international laboratory requirements.
No shipment classification, carrier documentation, or destination-specific regulatory authorization was supplied to substantiate those statements.
Laboratory inventory records should preserve the compound name, any available batch identifier, receipt details, and relevant storage observations.
The labeled blotter content should be recorded as a source-provided specification unless independently confirmed.
Where chemical form or formulation ingredients remain uncertain, the inventory record should preserve those uncertainties rather than assign unverified details. Deschloroetizolam Blotters
Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional laboratory procedures.
Intended Research Use & Market Positioning
The supplied scientific context places deschloroetizolam within analytical research involving thienotriazolodiazepine derivatives, chemical identification, structural comparison, and forensic toxicology.
Its proposed deschlorinated molecular framework provides a basis for differentiating it from related halogenated compounds in appropriately validated analytical investigations.
The source references chromatographic identification, mass-spectrometric characterization, and comparative examination of related heterocyclic structures.
These references describe laboratory research contexts and do not establish any human-use application.
The supplied Raw Lab Chems catalog references include Deschloroetizolam Blotters, corresponding to the preparation discussed here.
The catalog also includes Dechloroetizolam Pellets, a differently presented product with a variant spelling in its URL.
The supplied information does not establish whether the two products share identical chemical forms, ingredient purity, or analytical characteristics. Deschloroetizolam Blotters
These references provide chemical-catalog context rather than evidence of certified reference-material status or interchangeability.
Ordering, Availability & Fulfillment
The supplied source describes standardized laboratory-scale sheets, protective packaging, and professional international shipping arrangements.
However, no current inventory information, carrier record, destination-specific authorization, or verified shipment-performance documentation was provided.
Consequently, no specific availability, delivery, customs-clearance, or transportation-compliance guarantee is asserted.
Deschloroetizolam may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.
Institutional acquisition and transfer should therefore be assessed against the applicable laws governing the exact substance and chemical form involved.
Researchers and institutions should independently verify whether possession, importation, exportation, transportation, and laboratory investigation are authorized in their jurisdictions.
Research-only labeling does not establish an exemption from controlled-substance regulations.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Deschloroetizolam is a thienotriazolodiazepine-related compound whose acquisition, possession, transfer, importation, exportation, storage, and laboratory investigation may be restricted or prohibited under applicable controlled-substance, analogue, or other chemical regulations.
The exact legal classification and requirements may vary by jurisdiction. Deschloroetizolam Blotters
Researchers and institutions remain responsible for determining the applicable legal requirements and obtaining any necessary authorizations.
No medical approval, consumer-use authorization, universal legal status, or regulatory exemption is implied by this description.
| Quantity |
50 blotters ,100 blotters ,500 blotters ,1000 blotters |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.